Zhou Q - Search Results

1

Steeg PS, Zhou Q. Steeg PS, et al. Among authors: zhou q. Breast Cancer Res Treat. 1998;52(1-3):17-28. doi: 10.1023/a:1006102916060. Breast Cancer Res Treat. 1998. PMID: 10066069 Review.

2

Molecular analysis of premalignant and carcinoma in situ lesions of the human breast.

Steeg PS, Clare SE, Lawrence JA, Zhou Q. Steeg PS, et al. Among authors: zhou q. Am J Pathol. 1996 Sep;149(3):733-8. Am J Pathol. 1996. PMID: 8780376 Free PMC article. Review. No abstract available.

3

Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro.

Zhou Q, Stetler-Stevenson M, Steeg PS. Zhou Q, et al. Oncogene. 1997 Jul 3;15(1):107-15. doi: 10.1038/sj.onc.1201142. Oncogene. 1997. PMID: 9233783

4

Cyclin D1 overexpression in a model of human breast premalignancy: preferential stimulation of anchorage-independent but not anchorage-dependent growth is associated with increased cdk2 activity.

Zhou Q, Wulfkuhle J, Ouatas T, Fukushima P, Stetler-Stevenson M, Miller FR, Steeg PS. Zhou Q, et al. Breast Cancer Res Treat. 2000 Jan;59(1):27-39. doi: 10.1023/a:1006370603147. Breast Cancer Res Treat. 2000. PMID: 10752677

5

Radiation and the Apo2L/TRAIL apoptotic pathway preferentially inhibit the colonization of premalignant human breast cells overexpressing cyclin D1.

Zhou Q, Fukushima P, DeGraff W, Mitchell JB, Stetler Stevenson M, Ashkenazi A, Steeg PS. Zhou Q, et al. Cancer Res. 2000 May 15;60(10):2611-5. Cancer Res. 2000. PMID: 10825131

6

Cyclin D1 in breast premalignancy and early breast cancer: implications for prevention and treatment.

Zhou Q, Hopp T, Fuqua SA, Steeg PS. Zhou Q, et al. Cancer Lett. 2001 Jan 10;162(1):3-17. doi: 10.1016/s0304-3835(00)00657-1. Cancer Lett. 2001. PMID: 11121857 Review. No abstract available.

7

Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer.

Gernapudi R, Yao Y, Zhang Y, Wolfson B, Roy S, Duru N, Eades G, Yang P, Zhou Q. Gernapudi R, et al. Among authors: zhou q. Breast Cancer Res Treat. 2015 Apr;150(3):685-95. doi: 10.1007/s10549-015-3326-2. Epub 2015 Mar 18. Breast Cancer Res Treat. 2015. PMID: 25783182 Free PMC article.

8

A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells.

Yao Y, Zhou Q. Yao Y, et al. Among authors: zhou q. Breast Cancer Res Treat. 2010 May;121(1):233-40. doi: 10.1007/s10549-009-0547-2. Epub 2009 Sep 18. Breast Cancer Res Treat. 2010. PMID: 19760501

9

Inhibition of estrogen signaling activates the NRF2 pathway in breast cancer.

Yao Y, Brodie AM, Davidson NE, Kensler TW, Zhou Q. Yao Y, et al. Among authors: zhou q. Breast Cancer Res Treat. 2010 Nov;124(2):585-91. doi: 10.1007/s10549-010-1023-8. Epub 2010 Jul 10. Breast Cancer Res Treat. 2010. PMID: 20623181 Free PMC article.

10

Inhibition of histone deacetylase suppresses EGF signaling pathways by destabilizing EGFR mRNA in ER-negative human breast cancer cells.

Zhou Q, Shaw PG, Davidson NE. Zhou Q, et al. Breast Cancer Res Treat. 2009 Sep;117(2):443-51. doi: 10.1007/s10549-008-0148-5. Epub 2008 Aug 6. Breast Cancer Res Treat. 2009. PMID: 18683042

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,454 results

Search Page

Filters